340B Program Transparency – Is It “Trans-Fair-Ency”?


When you look at the developments and debates surrounding the 340B program in recent years, it reads like a microcosm of the larger healthcare landscape. Politics, economics, social factors and technology are at play within 340B, and the program can sometimes serve as a scapegoat for issues such as drug prices, political polarization, and general social discontent with healthcare delivery.

In order to truly understand the nuances of what’s been happening in the 340B program in recent years and the rationale behind the increased call for transparency, it’s necessary to first set the backdrop of where we are with healthcare overall.

There is a lot to keep up with in health care. Texas Healthcare Trustees is here to help our members, trustees of hospitals and health care systems throughout Texas, with resources that will help to stay up-to-date on important information that can impact how they lead their organization. THT’s Governance Thought Leadership Series is one of many resources THT has available for health care board members. To learn more about this series and to view other tools and resources available, visit www.tht.org.

Sentry Data Systems, a pioneer in automated pharmacy procurement, utilization management and 340B compliance, is leading the healthcare industry in turning real-time data into real-world evidence through Comparative Rapid Cycle Analytics™ to reduce total cost of care, improve quality and provide better results for all. More than 11,000 hospitals, clinics, integrated delivery networks and pharmacies across the country rely on Sentry’s unique proprietary data set for their analytics, procurement, drug utilization and compliance solutions.

Interested in providing content for THT’s Governance Thought Leadership Series? Contact Vicki Dale, Sr. Director, corporate relations, at [email protected] 512-465-1013

Opinions expressed in this publication do not necessarily reflect official policy of THT.